Original Contributions |
From the Heart Lung Institute, Utrecht University Hospital (B.J.G.L. de S., G.P., Y.J. van der H., C.B., M.J.P.), and the Interuniversity Cardiology Institute of the Netherlands (B.J.G.L. de S., G.P., M.J.P.), Utrecht, the Netherlands.
Correspondence to M.J. Post, MD, PhD, Beth IsraelDeaconess Medical Center, Cardiovascular Division, Cardiovascular Angiogenesis Center, 330 Brookline Ave, Boston MA 02215. E-mail mpost{at}bidmc.harvard.edu
| Abstract |
|---|
|
|
|---|
Key Words: remodeling intravascular ultrasound balloon angioplasty atherosclerosis restenosis
| Introduction |
|---|
|
|
|---|
In a recent serial IVUS study from our laboratory in human femoral arteries,10 we observed no difference in acute lumen gain between three categories of de novo atherosclerotic remodeling, ie, enlarged, unchanged, and shrunken arteries. However, the mechanism of acute gain by balloon angioplasty was different, showing more plaque reduction or axial redistribution of plaque in enlarged arteries and more stretch of the arterial wall (increase in MBA) in shrunken arteries.
Restenosis is the arithmetic sum of neointima formation,11 12 13 14 being a combination of smooth muscle cell hyperplasia, extensive matrix elaboration, and remodeling,5 6 7 8 9 and it is important for future therapeutic strategies to determine whether the relative contributions of neointima formation and remodeling are influenced by atherosclerotic remodeling. This study was designed to assess the relationship between atherosclerotic remodeling and the degree and mechanism of restenosis after balloon angioplasty. We performed serial IVUS, quantitative angiography, and histology in an atherosclerotic Yucatan micropig model and measured the geometric dimensions of lumen and area within the internal elastic membrane, in both reference and stenotic segments, before and after balloon angioplasty.
| Methods |
|---|
|
|
|---|
Atherogenic Diet and Anesthesia
In addition to essential nutrients, vitamins, and salts, 1.5%
cholesterol, 17.5% casein, 19.5% lard, and 0.5% bile
salts formed the basic atherogenic components of the diet that had a
daily nutritional value equivalent to 2400 kcal. In pilot experiments,
it had been shown that this regimen resulted in a sustained 15-fold
increase in total cholesterol and a 2.5-fold increase in
HDL level. Water intake was not restricted. The diet during follow-up
was a regular, nonatherogenic chow diet, with a nutritional value equal
to that of the atherogenic diet.
For denudation, intervention, and termination, the animals were anesthetized with intravenous metomidate (4 mg/kg body weight) and ventilated (Servo, EM 902) with a mixture of O2/N2O=1:2 (vol/vol) and 1% to 2% halothane. During each procedure, the animals were heparinized (100 IU/kg thromboliquine, Organon Technika) to an activated partial thromboplastin time of >80 seconds. Every 15 minutes, 0.25 mg atropine was given intravenously.
One day before intervention, dipyridamole 2 dd 250 mg (twice daily) and acetylsalicylic acid (125 mg) PO was given, and this regimen was continued for 2 weeks after intervention. During intervention and termination, a continuous infusion of nitroglycerin (20 µg/min) was given, and 10 mg nifedipine was administered through the nasogastric tube to prevent arterial spasm.
Procedures
For denudation, re-denudation, intervention, and termination,
the arterial tree was accessed through a carotid cutdown
and insertion of an arterial 8F sheath into the aorta
descendens under fluoroscopic guidance. For denudation and
redenudation, the left carotid artery was used. For intervention and
termination, the right carotid artery was used. An 8F guiding catheter
was advanced to the aortic bifurcation. Through this, contrast
(Telebrix, Laboratoire Guerbet) angiography was performed and the
Fogarty balloon catheter, the IVUS catheter, and the balloon
angioplasty catheter were advanced. After the denudations and
intervention, the carotid arteries were carefully sutured for
future interventions.
For both denudation procedures, 3- to 4-cm segments (measured by a radio-opaque ruler) in the iliac and femoral arteries were denuded by triple withdrawal of a 4F Fogarty catheter that was manually inflated with a 50:50 (vol/vol) water/contrast material mixture.
Five to 8 months after the second denudation, selected sites of angiographic arterial narrowing were balloon dilated. Before and after each intervention, angiography and IVUS were performed under fluoroscopic guidance. For balloon dilation, a standard peripheral (length, 2 to 4 cm; outer diameter, 4 to 7 mm) or coronary (length, 2 cm; diameter, 2 to 4 mm) balloon catheter was advanced over a 0.03-in. or a 0.014-in. guide wire. Because the diameter of the target vessels ranged from 1.5 to 6 mm and because the dilation ratio needed to be standardized, we used different balloon sizes. The mean dilation ratio, defined as the diameter of the inflated balloon on fluoroscopy divided by the angiographic diameter of the reference segment, was 1.21±0.16. The balloon was inflated three times for 1 minute at a pressure of 10 atm.
Termination
After a follow-up of 42 days, the pigs were
anesthetized and angiograms and IVUS measurements were made.
The animals were then killed (by bleeding) and the arteries were
harvested for histology and histomorphometry. To avoid collapse and
contraction of the arteries, they were pressure (60 mm Hg)
infused with a 50°C 3%/48.5%/48.5% (wk/vol/vol)
agar-agar/contrast/water gel that congealed at room temperature within
the arteries. After solidification of this mixture, the arteries were
submerged in situ under 4% formalin for 4 to 6 hours. With the aid of
anatomic markers (side branches) on intervention angiograms and
agar/contrast postmortem fluoroscopy, the balloon-dilated segments were
identified and marked with adventitial sutures.15
The arterial tree was then taken out en bloc and postfixed
for at least 24 hours.
Angiography and IVUS
Angiograms were performed before and after each intervention and
at follow-up. Contrast (Telebrix) was injected selectively into the
artery under study through an 8F guiding catheter. The fluoroscopy was
recorded at a cine rate of 12 images/s by using a digital C-arm
(Philips). The image with the highest contrast was selected and stored
on DAT tape for later analysis.
The angiographic diameters of the arteries were measured using a semi-automated program. The quantitative edge detection algorithm is applied to the digitized gray value of a proposed line perpendicular to the center axis of the lumen. The gray value distribution along the perpendicular line has its maximum outside the lumen and its minimum in the middle of the lumen. The edge of the lumen was defined by the position of the pixel with a gray value equal to the average of the maximum and minimum. The diameter of the artery was calculated by this full-width/half-maximum distance. In each artery, lumen diameters were measured at intervals of 0.5 cm, including the treated segment and a proximal and distal reference segment. Reference segments were chosen at a distance of at least 1 cm proximal to and distal from the balloon-dilated site. To use equal positions at different time points (preprocedure, postprocedure, and at follow-up), these positions were documented relative to an anatomic landmark. Angiography was calibrated by using a radio-opaque ruler.
The mean and minimum lumen diameters (MLD) of the lesion were determined. Angiographic acute gain was defined as the difference between postprocedure and preprocedure lumen diameters, and angiographic late lumen loss was defined as the difference between postprocedure and follow-up lumen diameters. Angiographic percent stenosis was calculated as (1-MLD/RLD)x100, where RLD is the distal reference segment. The site of stenosis was area of the treated site with the minimum lumen diameter.
IVUS recordings were made before and after intervention and at
follow-up by using a 30-MHz ultrasound transducer (Du-MED), which
rotated up to 16 times per second within a 4.1 French catheter. The
axial resolution of the system was 0.1 mm. The images were
displayed on a monitor and recorded on VHS videotape (Fig 1
). IVUS images were analyzed
with a digital video analyzer as described
previously.16 Fluoroscopy was performed during
IVUS so that the IVUS images were documented relative to an anatomic
landmark to match the IVUS images at different time points
(preprocedure, postprocedure, and follow-up). In the IVUS images, the
area circumscribed by the interface between the echodense intimal layer
and the echolucent media was manually traced and was designated as the
MBA. In addition, the LA was traced. Echographic acute gain was defined
as the difference between postintervention and preintervention LA, and
echographic late lumen loss as the difference between postintervention
and follow-up LA. In addition to late lumen loss, late MBA loss was
introduced to measure the remodeling after angioplasty. Late MBA loss
was defined as the difference between the postintervention MBA and
follow-up MBA at either the site of the initial stenosis or the
reference sites. To measure remodeling from de novo
atherosclerosis before balloon angioplasty, we used an
MBA index (relative MBA): MBA at the treated site divided by the MBA at
the reference site. A relative MBA >1.0 indicates enlargement, and
relative MBA <1.0 indicates shrinkage compared with the reference
site. Intimal area was defined as the difference between MBA and LA. At
follow-up, the intima is the sum of plaque and neointima
formation. Neointima formation is therefore calculated as
the difference between the intima at follow-up and that at
preintervention. Echographic percent stenosis is calculated as
1-minimum lumen area (MLA) divided by reference lumen area (RLA)
x100. The site of stenosis was the area of the treated sited
with the smallest LA.
|
Histology and Histomorphometry
After harvesting, the arteries were cut into 0.5-cm blocks and
embedded in paraffin. Serial sections of 5-µm thickness were cut at
intervals of 1 mm and stained with hematoxylin/eosin and van
Gieson's elastin stains. For morphometry, the elastin van
Gieson'sstained sections were used. Images of the sections were
filmed on a black-and-white film (camera model MX5/5010) mounted on
a Leitz microscope. The frames were digitized using a videograbber and
computer (Silicon Graphics) and analyzed with Analyze
(Biomedical Imaging Resource, Mayo Foundation). The lumen boundary and
the internal and external elastic laminas were manually traced, and
their perimeters and areas were measured. To correct for form
artifacts, the LA, internal elastic lamina area, and external elastic
lamina area were calculated from their perimeters after assuming
circular geometry. Analogous to the IVUS measurements, the intima was
calculated as the difference between the internal elastic lamina area
and LA.
Statistical Analysis
For statistical calculations, we used an average of the
entire treated site, the length of which varied with balloon length.
For IVUS and angiography, the number of cross sections analyzed
varied from 4 to 8 and for histology, from 5 to 10, both depending on
balloon length. The data were analyzed separately for the MLD.
All data in text and the Table
are
presented as mean±SD. SPSS 6.1 was used for all statistical
calculations. Pearson's correlation coefficients were calculated when
indicated.
|
| Results |
|---|
|
|
|---|
The average echographic stenosis was 21.7±24.6% (Table
). The
echographic acute gain at the treated site was 3.9
mm2 and ranged from 0.4 to 8.6
mm2 The echographic late lumen loss ranged from
to -2.0 to 15.4 mm2 and had an average of
4.5 mm2 The mean plaque area was
1.7±0.9 mm2
Histology Versus IVUS and IVUS Versus Angiography
Intimal area, which comprised preexisting plaque and
neointima formation as measured by IVUS and histology at
follow-up, respectively, was significantly correlated
(r=.62, P<.001), as illustrated by the
example of two corresponding cross sections (Fig 1
). The mean intimal area measured by
IVUS was 2.6±1.2 mm2. With histology, the
mean intimal area was 2.4±1.4 mm2.
Angiographic lumen diameter at the treated site was significantly
correlated with echographic LA at the treated site
(r=.73, P<.001). Also, angiographic
MLD was significantly correlated with echographic minimum LA
(r=.65, P<.001).
Acute GainLate Lumen Loss Relationships for the
Treated Site
Acute gain and dilation ratio are considered to reflect the
severity of injury imparted to the arterial wall.
Echographic acute gain was correlated significantly with echographic
late lumen loss (r=.48, P=.011). Also
for angiographic acute gain and late lumen loss, a significant
correlation was found (r=.67, P<.001).
The dilation ratio was also correlated significantly with angiographic
acute gain (r=.43, P=.027) but not with
echographic acute gain (r=-.09,
P=.66). The average neointima formation at
follow-up was 0.8±1.4 mm2 and was not
correlated with angiographic or echographic late lumen loss. Instead,
late MBA loss was correlated with angiographic late lumen loss and very
strongly with echographic late lumen loss (r=.39,
P=.046 and r=.95,
P<.001, respectively).
Acute GainLate Lumen Loss Relationships for the
MLD
Subanalysis with data for MLD revealed similar results,
with positive correlations between angiographic and echographic acute
gain and late lumen loss (r=.53, P=.005
and r=.77, P<.001, respectively) and a
positive correlation between dilation ratio and angiographic acute gain
(r=.65, P=.002) but no correlation
between dilation ratio and echographic acute gain
(r=-.18, P=.44). Also at the MLD, late
MBA loss was correlated with angiographic late lumen loss and
echographic late lumen loss (r=.44,
P=.036 and r=.94,
P<.001).
Remodeling in De Novo Atherosclerosis
Relative MBA before angioplasty ranged from 0.56 (shrinkage) to
1.66 (enlargement), with a mean of 0.99±0.23. The cumulative
distribution of the relative MBA is shown in Fig 2
. For the treated site, relative MBA
before angioplasty was not correlated with angiographic or echographic
acute gain after balloon dilation (r=.22,
P=.28 and r=.14, P=.48)
or with angiographic or echographic late lumen loss
(r=-.05, P=.81 and
r=.19, P=.33) and echographic
neointima formation at follow-up (r=.14,
P=.47). No correlation was found between relative MBA
before angioplasty and plaque before angioplasty
(r=.04, P=.85), as shown in Fig 3
.
|
|
Subanalysis of data at the MLD revealed similar results, with no correlations between relative MBA before angioplasty with angiographic and echographic acute gain (r=.27, P=.18 and r=-.11, P=.60) or with angiographic and echographic late lumen loss (r=-.11, P=.60 and r=.03, P=.90) and with echographic neointima formation at follow-up (r=.14, P=.52).
Remodeling in De Novo Atherosclerosis and
Remodeling After Balloon Angioplasty
We used the relative MBA before angioplasty as a measure of
remodeling in de novo atherosclerosis and late MBA loss
as a measure of remodeling after balloon angioplasty. Late MBA loss
ranged from -2.6 to 17.0 mm2, with an
average of 3.7±4.3 mm2. The cumulative
distribution of the late MBA loss is shown in Fig 4
. No correlation was found between
relative MBA and late MBA loss (r=.14 and
P=.48, as shown in Fig 5
). Also at the MLD, no correlation was
found between relative MBA and late MBA loss (r=.027,
P=.90).
|
|
Because vessel size can be a potentially confounding parameter, we also performed a multiple regression analysis entering vessel size and relative MBA as independent variables and MBA loss as the dependent variable. The multiple regression coefficient improved only slightly when relative MBA was entered (from r=.43 to r=.49), with an actual decrease in P value from .027 to .035 (due to one extra degree of freedom). Although vessel size is a predictor of MBA loss, it does not affect the weak and insignificant relation between relative MBA and MBA loss.
| Discussion |
|---|
|
|
|---|
In this combined angiographic, serial ultrasound, and histological study of an atherosclerosis model in the Yucatan micropig, we studied the influence of remodeling in de novo atherosclerosis on the acute and long-term outcomes after balloon angioplasty. The de novo atherosclerosis was induced by a combination of mechanical denudation and an atherogenic diet, 5 to 8 months before balloon angioplasty. Our principal findings are the following: (1) Both compensatory enlargement and shrinkage were observed in this model of de novo atherosclerosis in peripheral pig arteries. (2) Remodeling in de novo atherosclerosis was not correlated with acute gain or late lumen loss after balloon angioplasty. (3) Remodeling in atherosclerosis and remodeling after balloon angioplasty were not related.
Remodeling in De Novo Atherosclerosis
Compensatory enlargement of human coronary
arteries1 17 and human femoral
arteries2 in the presence of developing intimal
plaque has been reported by many investigators. Incomplete enlargement
and shrinkage have been observed in human
femoral2 and human
coronary3 arteries. In accordance with
these human studies, we observed the whole range of atherosclerotic
remodeling, from compensatory enlargement to shrinkage. Previously, we
reported that remodeling after balloon angioplasty importantly
determines restenosis in this model,7 to
an extent that has been reported in human coronary
arteries.5 Thus, this animal model seems to be
highly suited for the study of remodeling before and after
angioplasty.
The mechanism of remodeling in de novo atherosclerosis is still unknown. Zarins et al18 proposed two explanations of compensatory enlargement: (1) The local increase in wall shear stress caused by plaque development may stimulate endothelium-dependent arterial dilation. and/or (2) The development of plaque may lead to degradation of the media and adventitia, resulting in passive bulging of the plaque. We are currently studying proteolytic activity of plaque in this model to address this question.
Remodeling in Atherosclerosis: Angiographic and
Echographic Outcome
In this study, remodeling in de novo
atherosclerosis did not seem to be related to
angiographic and echographic acute gain. This finding is in accordance
with a recent study in human femoral arteries from our laboratory by
Pasterkamp et al.10 In human femoral arteries, we
observed less stretch of the arterial wall and more plaque
regression or axial plaque redistribution in the group wherein either
no de novo remodeling or compensatory enlargement was observed than in
the group with shrinkage. However, no differences in acute gain were
found.
Remodeling in De Novo Atherosclerosis and
Remodeling After Balloon Angioplasty
Several investigators have suggested that remodeling in
atherosclerosis may have relevance for acute and
long-term outcomes after balloon angioplasty.3 10
In this study, however, we found no relation between remodeling in
atherosclerosis and remodeling or late lumen loss after
balloon angioplasty. Whether this result is specific for the animal
model used in this investigation remains to be determined, although as
mentioned previously remodeling in this model seems to parallel
remodeling in human coronary arteries closely.
Comparison of IVUS and Histological Measurements
Although we observed a discrepancy between intimal area at
follow-up found on IVUS and histomorphometry, these measurements were
correlated significantly. Differences between these methodologies can
be explained by two factors. First, histological tissue
may shrink by 10% to 20% with dehydration, in spite of measures to
preserve lumen dimensions.19 This explains
possible underestimation of the intima by histology. Second, in
ultrasound measurements, not only the intima but also the lumen appears
larger than in histological or angiographic
measurements, suggesting systematic overestimation by IVUS. Other
investigators have observed a similar overestimation by
IVUS.20 21
Limitations of the Study
This study was performed in peripheral arteries in an
animal model of complex atherosclerosis, and it remains
to be determined whether our findings are
representative of the human situation. Recent serial
IVUS studies by Mintz et al4 5 and Di Mario et
al6 showing that remodeling after balloon
angioplasty contributes significantly to restenosis confirmed
their initial findings7 8 9 22 in earlier clinical
and animal studies. Since our model involves an initial balloon injury,
we cannot exclude the possibility that the mechanism of de novo
remodeling in our model differs from true atherosclerotic remodeling.
However, by creating this model, we succeeded in mimicking the human
condition as closely as possible, at least with regard to the presence
of a range of remodeling. It is unlikely that the initial injury still
influences the response to the second injury, as these events took
place 4 months apart. Although the arteries contained considerable
plaques, with an average of 1.7±0.9 mm2,
the angiographic stenoses were mild, and therefore it remains
unknown whether progression of the atherosclerotic lesion to a more
severe stenosis would have influenced the results.
The late lumen loss and late MBA loss observed in this study might be explained by acute and delayed elastic recoil, as we did not include early (eg, 24-hour) follow-up. However, in previous experiments, we did include a 48-hour follow-up group and found no early lumen loss or early MBA loss by elastic recoil.23 Furthermore, Kimura et al24 showed in the SURE study using serial IVUS that there was no difference between LA immediately after balloon dilation and the lumen 24 hours after balloon angioplasty. Taken together, it is highly unlikely that acute or delayed elastic recoil accounted for late MBA loss in this study.
Conclusions
In the atherosclerotic Yucatan micropig model, remodeling during
de novo atherosclerosis has no relevance for the acute
gain and late lumen loss after balloon angioplasty. Both the direction
of remodeling, ie, whether the artery enlarges or shrinks, and the
extent of remodeling after balloon angioplasty are unrelated to the
direction and extent of remodeling during de novo
atherosclerosis.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received May 12, 1997; accepted November 7, 1997.
| References |
|---|
|
|
|---|
2.
Pasterkamp G, Wensing PJW, Post MJ, Hillen B, Mali
WPTM, Borst C. Paradoxical arterial wall shrinkage
contributes to luminal narrowing of human femoral arteries.
Circulation. 1995;91:14441449.
3. Nishioka T, Luo H, Eigler NL, Berglund H, Kim C-J, Siegel RJ. contribution of inadequate compensatory enlargement to development of human coronary artery stenosis: an in vivo intravascular ultrasound study. J Am Coll Cardiol. 1996;27:15711576.[Abstract]
4.
Mintz GS, Kent KM, Pichard AD, Satler LF, Popma JJ,
Leon MB. Contribution of inadequate arterial remodeling to
the development of focal coronary artery stenoses: an
intravascular ultrasound study. Circulation. 1997;95:17911798.
5.
Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler
LF, Wong SC, Hong MK, Kovach JA, Leon MB. Arterial
remodeling after coronary angioplasty: a serial intravascular
ultrasound study. Circulation. 1996;94:3543.
6. Di Mario C, Gil R, Camenzind E, Ozaki Y, Von Birgelen C, Umans VA, De Jaegere P, de Feyter PJ, Roelandt JRTC, Serruys PW. quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional atherectomy. Am J Cardiol. 1995;75:772777.[Medline] [Order article via Infotrieve]
7.
Post MJ, Borst C, Kuntz RE. The relative importance of
arterial remodeling compared with intimal hyperplasia in
lumen renarrowing after balloon angioplasty: a study in the normal
rabbit and the hypercholesterolemic Yucatan micropig.
Circulation. 1994;89:28162821.
8.
Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon
DP. Differences in compensatory vessel enlargement, not intimal
formation, account for restenosis after angioplasty in the
hypercholesterolemic rabbit model.
Circulation. 1994;89:28092815.
9.
Lafont A, Guzman LA, Whitlow PL, Goormastic M,
Cornhill JF, Chisolm GM. Restenosis after experimental
angioplasty: intimal, medial, and adventitial changes associated with
constrictive remodeling. Circ Res. 1995;76:9961002.
10. Pasterkamp G, Borst C, Gussenhoven EJ, Mali WP, Post MJ, The SH, Reekers JA, van den Berg FG. Remodeling of de novo atherosclerotic lesions in femoral arteries: impact on mechanism of balloon angioplasty. J Am Coll Cardiol. 1995;26:422428.[Abstract]
11. Ellis SG, Muller DWM. Arterial injury and the enigma of coronary restenosis. J Am Coll Cardiol. 1992;19:275277.[Medline] [Order article via Infotrieve]
12. Schwartz RS, Holmes DR, Jr, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol. 1992;20:12841293.[Abstract]
13. Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H, Hamasaki N, Yokoi H, Kim K. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol. 1991;17:433439.[Abstract]
14.
Liu MW, Roubin GS, King SB3. Restenosis after
coronary angioplasty: potential biologic determinants and role
of intimal hyperplasia. Circulation. 1989;79:13741387.
15.
De Smet BJGL, Kuntz RE, van der Helm YJ, Pasterkamp G,
Borst C, Post MJ. Relationship between plaque mass and
neointimal hyperplasia after stent placement in Yucatan
micropigs. Radiology. 1997;203:484488.
16. Wenguang L, Gussenhoven EJ, Zhong Y, The SH, Di Mario C, Madretsma GS, Van Egmond F, de Feyter PJ, Pieterman H, Van Urk H. Validation of quantitative analysis of intravascular ultrasound images. Int J Card Imaging. 1991;6:247253.[Medline] [Order article via Infotrieve]
17. McPherson DD, Sirna SJ, Hiratzka LF, Thorpe L, Armstrong ML, Marcus ML, Kerber RE. Coronary arterial remodeling studied by high-frequency epicardial echocardiography: an early compensatory mechanism in patients with obstructive coronary atherosclerosis. J Am Coll Cardiol. 1991;17:7986.[Abstract]
18. Zarins CK, Weisenberg E, Kolettis G, Stankunavicius R, Glagov S. Differential enlargement of artery segments in response to enlarging atherosclerotic plaques. J Vasc Surg. 1988;7:386394.[Medline] [Order article via Infotrieve]
19. Siegel RJ, Swan K, Edwalds G, Fishbein MC. Limitations of postmortem assessment of human coronary artery size and luminal narrowing: differential effects of tissue fixation and processing on vessels with different degrees of atherosclerosis. J Am Coll Cardiol. 1985;5:342346.[Abstract]
20. De Scheerder I, De Man F, Herregods MC, Wilczek K, Barrios L, Raymenants E, Desmet W, De Geest H, Piessens J. Intravascular ultrasound versus angiography for measurement of luminal diameters in normal and diseased coronary arteries. Am Heart J. 1994;127:243251.[Medline] [Order article via Infotrieve]
21. Porter TR, Radio SJ, Anderson JA, Michels A, Xie F. Composition of coronary atherosclerotic plaque in the intima and media affects intravascular ultrasound measurements of intimal thickness. J Am Coll Cardiol. 1994;23:10791084.[Abstract]
22. Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Leon MB. Intravascular ultrasound comparison of restenotic and de novo coronary artery renarrowings. Am J Cardiol. 1994;74:12781280.[Medline] [Order article via Infotrieve]
23.
Post MJ, De Smet BJGL, van der Helm YJ, Borst C, Kuntz
RE. Arterial remodeling after balloon angioplasty or
stenting in an atherosclerotic experimental model.
Circulation. 1997;96:9961003.
24. Kimura T, Kaburagi S, Yokoi H, Nakagawa Y, Tamura T, Nosaka H, Nobuyoshi M, Mintz GS, Popma JJ, Leon MB. Time course of vessel response after coronary angioplasty: final result of serial ultrasound restenosis (SURE) study. Circulation. 1996;94:I-135.
This article has been cited by other articles:
![]() |
A. G. Touchard and R. S. Schwartz Preclinical Restenosis Models: Challenges and Successes Toxicol Pathol, January 1, 2006; 34(1): 11 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Bentzon, G. Pasterkamp, and E. Falk Expansive Remodeling Is a Response of the Plaque-Related Vessel Wall in Aortic Roots of ApoE-Deficient Mice: An Experiment of Nature Arterioscler. Thromb. Vasc. Biol., February 1, 2003; 23(2): 257 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yin, C. Yutani, Y. Ikeda, K. Enjyoji, H. Ishibashi-Ueda, S. Yasuda, Y. Tsukamoto, H. Nonogi, Y. Kaneda, and H. Kato Tissue factor pathway inhibitor gene delivery using HVJ-AVE liposomes markedly reduces restenosis in atherosclerotic arteries Cardiovasc Res, December 1, 2002; 56(3): 454 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Numaguchi, K. Naruse, M. Harada, H. Osanai, S. Mokuno, K. Murase, H. Matsui, Y. Toki, T. Ito, K. Okumura, et al. Prostacyclin Synthase Gene Transfer Accelerates Reendothelialization and Inhibits Neointimal Formation in Rat Carotid Arteries After Balloon Injury Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 727 - 733. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |